UNSPSC 51262500: Adrenergic blocking agent guanidines

This classification denotes adrenergic blocking agents made from a family of iminourea derivatives.

UNSPSC 51262500 Adrenergic blocking agent guanidines is a Class code that does not align with current state and local procurement activity. The single recent solicitation in the record—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—involves emergency-response pharmaceuticals and harm-reduction equipment that fall outside the nominal scope of adrenergic blocking agents used in hypertension and cardiac management. The mismatch between the code's pharmaceutical classification and the actual goods being procured suggests either a tagging error in the source or a systematic misalignment between this code and how state and local jurisdictions categorize naloxone and drug deactivation procurement.

Seminole County posted the naloxone solicitation on June 30, 2026, with a response deadline of July 26, 2023—a date inconsistency within the source itself that raises questions about data currency. The county sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with all shipping costs included in bids. Vendors were required to comply with E-Verify, drug-free workplace certification, and specified insurance coverage, and the contract included a three-month probationary period. The procurement offered an initial two-year term with a one-year renewal option. No other recent state and local opportunities appear under this code, indicating minimal current activity that matches the adrenergic blocking agent classification.